![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png){kind=small}
http://cnmnewsnetwork.com/1548/guardasil-could-benefit-gay-men-and-older-women/
Last heard, the FDA did not approve Gardasil for women over 26. Men and boys were only recently given FDA approval, but for older women, the FDA wanted more proof that it would do any good. The reasoning behind the FDA's rejection is that, the older a woman is, the more likely she is to have been exposed to HPV, and the less likely the vaccine is to do any good once she already has HPV.
Yes, yes, I already know all the logical fallacies in that argument, I'm not agreeing with them, I'm reporting it.
So Merck, data in hand from all their existing research that says it helps a little, dutifully went back and researched some more.
And they found that the vaccine does, indeed, significantly protect older women and gay men.
Merck submitted their request for approval in January, and it typically takes 6 months to review the data & receive approval or rejection.
Last heard, the FDA did not approve Gardasil for women over 26. Men and boys were only recently given FDA approval, but for older women, the FDA wanted more proof that it would do any good. The reasoning behind the FDA's rejection is that, the older a woman is, the more likely she is to have been exposed to HPV, and the less likely the vaccine is to do any good once she already has HPV.
Yes, yes, I already know all the logical fallacies in that argument, I'm not agreeing with them, I'm reporting it.
So Merck, data in hand from all their existing research that says it helps a little, dutifully went back and researched some more.
And they found that the vaccine does, indeed, significantly protect older women and gay men.
" A study showed that women ages 25 to 45 had an 89% effective rate of preventing certain strains of the HPV virus.
Gay men could benefit from Gardasil because the vaccine is shown to be 78% effective in preventing anal intraepithelial neoplasia, a precursor to anal cancer."
Gay men could benefit from Gardasil because the vaccine is shown to be 78% effective in preventing anal intraepithelial neoplasia, a precursor to anal cancer."
Merck submitted their request for approval in January, and it typically takes 6 months to review the data & receive approval or rejection.
